NOTES TO FINANCIAL STATEMENTS
Six Months Ended June 30, 2020
(Unaudited)
NOTE 1 – GOING CONCERN
As reflected in the accompanying financial
statements, the Company has a working capital deficiency of $2,170,084 and a stockholder’s deficiency of $1,959,973 and used
$525,007 of cash in operations for the six months ended June 30, 2020. This raises substantial doubt about its ability to continue
as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise
additional capital and implement its business plan. The financial statements do not include any adjustments that might be necessary
if the Company is unable to continue as a going concern.
Management believes that the actions presently
being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue
as a going concern.
NOTE 2 – DESCRIPTION OF BUSINESS AND
SUMMARY OF ACCOUNTING POLICIES
Description of Business
On May 16, 2011, the Company transferred, through
a spin-off to its then wholly owned subsidiary, Worlds Online Inc. (currently called MariMed Inc.), the majority of its
operations and related operational assets. The Company retained its patent portfolio which it intends to continue to increase and
to more aggressively enforce against alleged infringers.
Basis of Presentation
The accompanying financial statements have
been prepared in conformity with accounting principles generally accepted in the United States of America ("US GAAP").
The Company has incurred significant losses since its inception and has had minimal revenues from operations. The Company will
require substantial additional funds for development and enforcement of its patent portfolio. There can be no assurance that the
Company will be able to obtain the substantial additional capital resources to pursue its business plan or that any assumptions
relating to its business plan will prove to be accurate. The Company has not been able to generate sufficient revenue or obtain
sufficient financing which has had a material adverse effect on the Company, including requiring the Company to reduce operations.
As the Company has focused its attention on increasing its patent portfolio and enforcing it, the Company has been operating at
a reduced capacity, with only one employee and using consultants to perform any additional work that may be required.
Use of Estimates
The preparation of financial statements in
conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues
and expenses during the reporting period. Actual results could differ from these estimates.
Cash and Cash Equivalents
Cash and cash equivalents includes highly liquid
money market instruments, which have original maturities of three months or less at the time of purchase.
Revenue Recognition
Effective January 1, 2018, the Company adopted
ASC 606. There was no impact in adopting ASC 606 as the Company has no revenue at this time. In the second quarter of 2011, the
Company spun off its online businesses to MariMed Inc. (then called Worlds Online, Inc.). The Company’s sources of revenue
after the spinoff was expected to be from sublicenses of the patented technology by Worlds Online and any revenue that may be generated
from enforcing its patents. The Company recognizes revenue by applying the following steps: (1) identify the contract with a customer;
(2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price
to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.
Research and Development Costs
Research and development costs are charged
to operations as incurred.
Property and Equipment
Property and equipment are stated at cost.
Depreciation is provided on a straight line basis over the estimated useful lives of the assets ranging from three to five years.
When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting
gains or losses are included in income. Maintenance and repairs are charged to expense in the period incurred.
Impairment of Long Lived Assets
The Company evaluates the recoverability of
its fixed assets and other assets in accordance with section 360-10-15 of the FASB Accounting Standards Codification for disclosures
about Impairment or Disposal of Long-Lived Assets. Disclosure requires recognition of impairment of long-lived assets in the event
the net book value of such assets exceeds its expected cash flows. If so, it is considered to be impaired and is written down to
fair value, which is determined based on either discounted future cash flows or appraised values. The Company adopted the statement
on inception. No impairments of these types of assets were recognized during 2019 and 2018.
Stock-Based Compensation
The Company accounts for stock-based compensation
using the fair value method following the guidance set forth in section 718-10 of the FASB Accounting Standards Codification for
disclosure about Stock-Based Compensation. This section requires a public entity to measure the cost of employee services received
in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That
cost will be recognized over the period during which an employee is required to provide service in exchange for the award (usually
the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite
service.
Income Taxes
The Company accounts for income taxes under
Section 740-10-30 of the FASB Accounting Standards Codification. Deferred income tax assets and liabilities are determined based
upon differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax
rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation
allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets
and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates
is recognized in the consolidated statements of operations in the period that includes the enactment date.
ASC 740 prescribes a comprehensive model for
how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected
to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more
likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently
be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement
with the tax authority assuming full knowledge of the position and relevant facts.
Notes Payable
The Company has $773,279 in short term notes
outstanding at June 30, 2020 and December 31, 2019. These are old notes payable for which the statute of limitations has passed
and therefore the Company does not expect it will ever have to repay those notes.
Comprehensive Income (Loss)
The Company reports comprehensive income and
its components following guidance set forth by section 220-10 of the FASB Accounting Standards Codification which establishes standards
for the reporting and display of comprehensive income and its components in the financial statements. There were no items of comprehensive
income (loss) applicable to the Company during the period covered in the financial statements.
Loss Per Share
Net loss per common share is computed pursuant
to section 260-10-45 of the FASB ASC. Basic net loss per share is computed by dividing net loss by the weighted average number
of shares of common stock outstanding during the period. As of June 30, 2020 and June 30, 2019, there were 11,020,000 options and
4,380,000 warrants outstanding whose effect is anti-dilutive and not included in net loss per share for June 30, 2020 or for June
30, 2019. The options and warrants may dilute future earnings per share.
Commitments and Contingencies
The Company follows subtopic 450-20 of the
FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the
financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future
events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise
of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims
that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as
well as the perceived merits of the amount of relief sought or expected to be sought therein.
If the assessment of a contingency indicates
that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated
liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material
loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent
liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.
Loss contingencies considered remote are generally
not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based
upon information available at this time, that these matters will have a material adverse effect on the Company’s financial
position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely
affect the Company’s business, financial position, and results of operations or cash flows.
During 2000 the Company was involved in a lawsuit
relating to unpaid consulting services. In April, 2001 a judgment against the Company was rendered for approximately $205,000.
As of June 30, 2020, and December 31, 2019 the Company recorded a reserve of $205,000 for this lawsuit, which is included in accrued
expenses in the accompanying balance sheets.
Risk and Uncertainties
The Company is subject to risks common to companies
in the technology industries, including, but not limited to, litigation, development of new technological innovations and dependence
on key personnel.
Off Balance Sheet Arrangements
The Company does not have any off-balance sheet
arrangements.
Uncertain Tax Positions
The Company did not take any uncertain tax
positions and had no adjustments to unrecognized income tax liabilities or benefits pursuant to the provisions of Section 740-10-25
for the year ended December 31, 2019.
Fair Value of Financial Instruments
The Company measures assets and liabilities
at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents
the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction
between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset
or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value
on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.
The following are the hierarchical levels of
inputs to measure fair value:
|
•
|
Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
|
|
•
|
Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
|
|
•
|
Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.
|
The carrying amounts of the Company’s
financial assets and liabilities, such as cash, other receivables, accounts payable & accrued expenses, due to related party,
notes payable and notes payables, approximate their fair values because of the short maturity of these instruments. The Company's
convertible notes payable are measured at amortized cost.
Warrant and option expense was measured by
using level 3 valuation.
Embedded Conversion Features
The Company evaluates embedded conversion features
within convertible debt under ASC 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s)
should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded
in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC
470-20 “Debt with Conversion and Other Options” for consideration of any beneficial conversion feature.
Derivative Financial Instruments
The Company does not use derivative instruments
to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including
stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives.
For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at
its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income.
For option-based simple derivative financial
instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent
valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities
or as equity, is re-assessed at the end of each reporting period.
Recent Accounting Pronouncements
The Company has reviewed all recently issued,
but not yet effective, accounting pronouncements, and does not believe the future adoption of any such pronouncements may be expected
to cause a material impact on its financial condition or the results of its operations.
The Company accounts for stock-based
compensation for employees and directors in accordance with Accounting Standards Codification 718, Compensation (“ASC 718”)
as issued by the Financial Accounting Standards Board (“FASB”). ASC 718 requires all share-based payments to employees,
including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the
provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and
are recognized as an expense over the employee’s requisite service period (generally the vesting period of the equity grant).
The fair value of the Company’s common stock options are estimated using the Black Scholes option-pricing model with the
following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses
stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess tax benefits realized from the
exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits and tax deficiencies
(including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit in the condensed
consolidated statements of operations. The Company accounts for stock-based compensation awards issued to non-employees for services,
as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services,
whichever is more readily determinable, using the measurement date guidelines enumerated in ASU 2018-07.
In February 2016, the FASB issued Accounting
Standards Update 2016-02, “Leases” Topic 842, which amends the guidance in former ASC Topic 840, Leases.
The new standard increases transparency and comparability most significantly by requiring the recognition by lessees of right-of-use
assets and lease liabilities on the balance sheet for all leases longer than 12 months. Under the standard, disclosures are required
to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising
from leases. For lessees, leases will be classified as finance or operating, with classification affecting the pattern and
classification of expense recognition in the income statement. The Company adopted the new lease guidance effective January 1,
2019. The Company is not a party to any leases and therefore is not showing any asset or liability related to leases in the
current period or prior periods.
NOTE 3 - NOTES PAYABLE
|
Notes payable at June 30, 2020 consist of the following:
|
|
|
|
Unsecured note payable bearing 8% interest,
|
|
|
|
|
|
entire balance of principal and unpaid interest due on demand
|
|
$
|
124,230
|
|
|
Unsecured note payable bearing 10% interest,
|
|
|
|
|
|
entire balance of principal and unpaid interest due on demand
|
|
$
|
649,049
|
|
|
Total notes
|
|
$
|
773,279
|
|
|
2020
|
|
$
|
773,279
|
|
|
2021
|
|
$
|
-0-
|
|
|
2022
|
|
$
|
-0-
|
|
|
2023
|
|
$
|
-0-
|
|
|
2024
|
|
$
|
-0-
|
|
|
|
|
$
|
773,279
|
|
The Company imputed interest of $37,837 on
the notes during the six months ended June 30, 2020. The Company repaid the $600,000 in notes payable and $150,000 in notes payable
related party with accrued interest totaling $189,118 during the six months ended June 30, 2019.
NOTE 4 - EQUITY
All common stock numbers and exercise prices
in this Note are reflected on a post reverse split (5 to 1) basis. As a result of the reverse split on February 9, 2018, the Company
had to issue an additional 167 shares due to rounding.
During the six months ended June 30, 2020,
the Company recorded an option expense of $187,546 representing the amortization of the value of the options issued in 2018 that
have not yet vested.
During the six months ended June 30, 2019,
the Company recorded an option expense of $54,471 representing the amortization of the value of the options issued in 2018 that
have not yet vested.
|
Stock Warrants and Options
|
|
Stock warrants/options outstanding and exercisable on June 30, 2020 are as follows:
|
|
|
|
Exercise Price per Share
|
|
Shares Under Option/warrant
|
|
Remaining Life in Years
|
|
Outstanding
|
|
|
|
|
|
$
|
0.325
|
|
|
|
3,500,000
|
|
|
|
3.58
|
|
|
$
|
0.15
|
|
|
|
5,220,000
|
|
|
|
2.25
|
|
|
$
|
0.15
|
|
|
|
580,000
|
|
|
|
0.45
|
|
|
$
|
0.05
|
|
|
|
200,000
|
|
|
|
2.45
|
|
|
$
|
0.30
|
|
|
|
200,000
|
|
|
|
2.45
|
|
|
$
|
0.25
|
|
|
|
5,000,000
|
|
|
|
3.17
|
|
|
$
|
0.24
|
|
|
|
800,000
|
|
|
|
3.17
|
|
|
Exercisable
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.325
|
|
|
|
3,500,000
|
|
|
|
3.58
|
|
|
$
|
0.15
|
|
|
|
5,220,000
|
|
|
|
2.25
|
|
|
$
|
0.15
|
|
|
|
580,000
|
|
|
|
0.45
|
|
|
$
|
0.05
|
|
|
|
200,000
|
|
|
|
2.45
|
|
|
$
|
0.30
|
|
|
|
200,000
|
|
|
|
2.45
|
|
|
$
|
0.25
|
|
|
|
3,500,000
|
|
|
|
3.17
|
|
|
$
|
0.24
|
|
|
|
800,000
|
|
|
|
3.17
|
|
NOTE 5 - COMMITMENTS AND CONTINGENCIES
The Company is committed to an employment agreement
with its President and CEO, Thom Kidrin. The agreement, dated as of August 28, 2018, is for five years with a one-year renewal
option held by Mr. Kidrin. The agreement provides for a base salary of $200,000, which increases 10% on September 1 of each
year; a monthly car allowance of $500; an annual bonus equal to 2.5% of Pre-Tax Income (as defined in the agreement); an additional
bonus as follows: $75,000, if Pre-Tax Income for the year is between 150% and 200% of the prior fiscal year’s Pre-Tax Income
or (B) $100,000, if Pre-Tax Income for the year is between 201% and 250% of the prior fiscal year’s Pre-Tax Income or (C)
$200,000, if Pre-Tax Income for the year is 251% or greater than the prior fiscal year’s Pre-Tax Income, but in no event
shall this additional bonus exceed five (5%) percent of Pre-Tax Income for such year; payment of up to $10,000 in life insurance
premiums; options to purchase 5 million shares of Worlds Inc. common stock at an exercise price of $0.25 per share, 2 million
of which vested on August 28, 2018, 1.5 million shall vest on August 28, 2019 and the remaining 1.5 million shall vest on August
28, 2020 ; a death benefit of at least $2 million dollars; and a payment equal to 2.99 times his base amount (as defined in the
agreement) in the event of a Change of Control (as defined in the agreement). The agreement also provides that Mr. Kidrin
can be terminated for cause (as defined in the agreement) and that he is subject to restrictive covenants for 12 months after termination.
NOTE 6 - RELATED PARTY TRANSACTIONS
The Company paid $150,000 in notes payables
with accrued interest to related parties during the six months ended June 30, 2019.
The balance in the accrued expense attributable
to related parties is $74,312 and $341,624 at June 30, 2020 and December 31, 2019, respectively.
NOTE 7 - PATENTS
Worlds Inc. currently has nine patents, 6,219,045
- 7,181,690 - 7,493,558 – 7,945,856, - 8,082,501, – 8,145,998 – 8,161,383, – 8,407,592 and 8,640,028. On
March 30, 2012, the Company filed a patent infringement lawsuit against Activision Bizzard Inc., Blizzard Entertainment Inc. and
Activision Publishing Inc. in the United States District Court for the District of Massachusetts. On September 20, 2019, the Company
filed a lawsuit against Linden Research, Inc. in the US District court for the District of Delaware. Davidson, Berquist, Jackon
& Gowdey LLP is lead counsel for the Company.
There can be no assurance that the Company
will be successful in its ability to prosecute its IP portfolio or that we will be able to acquire additional patents.
NOTE 8 – ACCRUED EXPENSES
Accrued expenses is comprised of $74,312 owed
to related parties. $205,000 is related to a judgment against the Company relating to unpaid consulting services dating back to
April of 2001. $1,305,009 is related to old accruals for which the statute of limitations has passed and therefore the Company
does not expect it will ever have to repay those amounts. The balance of $52,219 is related to accruals for recurring operating
expenses.
NOTE 9 – CONVERTIBLE NOTE RECEIVABLE
– RELATED PARTY
The Company made an investment in the form
of a convertible note in the amount of $200,000 to Canadian American Standard Hemp (CASH). The convertible note has a 7% annual
interest rate and matures in 2 years. Interest and principle is payable at maturity. The note can be converted at any time and
either all or part of the amount due can be converted into the borrowers equity at a price of $0.50 per share. If converted into
common stock, the Company would own 1% of CASH based upon current number of CASH shares outstanding. Messrs. Kidrin, Toboroff and
Christos are Directors of CASH and Mr. Kidrin is the CEO and Mr. Ryan is the CFO of CASH.
During the six months ended June 30, 2020,
the Company earned $7,078 in interest on the note.
NOTE 10 – SUBSEQUENT EVENTS
The Company reviewed for subsequent events
and there are none to report.
